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The eﬀects of dietary protein and fat on renal function-related blood and urine parameters, such as albumin, urinary protein,and
inﬂammatory cytokines were investigated in adriamycin- (ADR) induced nephrotic syndrome rats. ADR (2mg/kg BW) was
injected i.p. weekly for six weeks to develop nephrotic syndrome; thereafter rats were fed low-protein/high-fat (LPHF) or high-
protein/low-fat (HPLF) diets for ﬁve weeks. Renal function-related blood and urine parameters were measured before and after
dietary intervention. Serum levels of albumin, TG, and creatinine were signiﬁcantly higher in the LPHF group than in the HPLF
group. Serum levels of albumin were low and urinary protein excretion protein was high in HPLF group. BUN and UUN levels
were higher in the HPLF group than in the LPHF. Urinary excretion of creatinine was signiﬁcantlyhigher in the HPLF group than
in the LPHF group. Serum inﬂammatorycytokine levels did notdiﬀer between the two groups, however the levels of IL-6, TNF-α,
and IL-13 in splenocyte supernatants were signiﬁcantly higher in the LPHF group than in the HPLF group. We conﬁrmed that
protein and fat contents in diet aﬀect renal function-related blood and urine parameters and splenocyte inﬂammatory cytokine
levels in ADR-induced nephrotic syndrome rats.
1.Introduction
Nephrotic syndrome (NS) is a general symptom of renal
disease and is associated with abnormal immune response
[1–3]. Nephrotic syndrome shows symptoms of hypoal-
buminemia, hyperlipidemia, and proteinuria. It has been
reported that dietary protein and fat aﬀect the symptoms of
nephrotic syndrome. Chronic degenerative diseases such as
hyperlipidemia, hypertension, atherosclerosis, and diabetes
mellitus promote renal function decline.
Animal study showed that hyperlipidemia could damage
renal vascular endothelial cells and cause glomerular inter-
stitial cell proliferation by increasing platelet aggregation
and platelet-derived growth factor levels [4]. Glomerular
interstitialcellproliferationincreaseslow-densitylipoprotein
cholesterol (LDL-chol) and free radical generation [5].
High-fat-diet-induced obesity causes hyperlipidemia show-
ing structural and functional damages such as increased
glomerular ﬁltration rate (GFR), increased renal blood ﬂow
(RBF), and renal hypertrophy, as shown in both animal
models and humans [6, 7].
Excessive protein intake may cause and accelerate kidney
damage, and restricting dietary protein could prevent a
decline in renal function and eﬀectively protect the kidneys
in animals [8]. Clinical trials have yet to determine the
eﬃciency of this protocol [9]. Restricting dietary protein
in renal patients increases exposure to malnutrition risk
compared to that of normal people [9, 10]. Nevertheless,
a nutrition treatment used for NS patients in Korea only
focuses on restricting protein [10, 11]
Cytokines are polypeptides that serve as cell-to-cell
messengers. In patients relapsed into nephrotic syndrome,2 Mediators of Inﬂammation
cytokines secreted from T cells increase glomerular per-
meability to protein [12]. Several studies have shown
that nephrotic syndrome is associated with the presence
of circulating permeability factors and complex immune
system disturbances [13]. It seems that T-cell activation is
involved in NS pathogenesis; however, the roles of speciﬁc
cytokines are not clear [14, 15]. A previous study reported
that TNF-α and IL-6 levels increased signiﬁcantly in the
NS animal model [16]. Expressions of anti-inﬂammatory
cytokines are changed signiﬁcantly in animals and human
with nephrotic syndrome. A previousstudy reported that IL-
4 and IL-10 were able to downregulate the release of vascular
permeability factor in NS patients [17].
Therefore, we investigated the eﬀects of dietary protein
and fat contents on renal function and inﬂammatory
cytokine levels in adriamycin- (ADR-) induced nephrotic
syndrome rats [1].
2.Materialsand Methods
2.1. Study Design. After two weeks of adaptation in a meta-
bolic cage, animals received weekly 1.0mL intraperitoneal
injections of 2mg/kgBW adriamycin (ADR) for six weeks
(n = 20), after which, nephrotic syndrome was conﬁrmed
though proteinuria. ADR-treated animals were then placed
into one of two diﬀerent diet groups, a low-protein high-fat
diet group,LPHF,or a high protein-low fat diet group, HPLF
forﬁveweeks.Bothdietscontainedequalamountsofcalories
to prevent eﬀects due to the diﬀerences in calorie intake.
Body weight and food intake were measured weekly.
The food eﬃciency ratio (FER) was calculated according
to the following formula: (weight gain(g)/day)/(amount of
food consumed(kcal)/day). Blood samples were obtained
via heart puncture, and the organs (heart, liver, kidney,
and spleen) were weighed after the animal was sacriﬁced.
Blood and urine were collected at 0 and ﬁve weeks after
experimental diets were fed.
2.2. Animals and Diets. The experimental protocol was
approved by the Animal Care and Use Review Committee
(IACUC) of Kyung Hee University. A total of 20 four-
week-old male Sprague-Dawley rats with body weights
ranging from 150 to 170g were purchased from SLC, Inc
(Shizuoka, Japan). Rats were housed in polycarbonate cages
in temperature-controlled rooms (22±2◦C), with a relative
humidity of 55±5%, and a 12-h light/dark cycle. The
m i c ew e r ef e dap e l l e tc h o wd i e ta n dw e r eg i v e nw a t e ra d
libitum for an adaption period of two weeks. After two
weeks,ratswere injectedintraperitoneally (i.p.)with2mg/kg
BW adriamycin (ADR, Doxorubicin, Sigma St Louis USA,
D1515) weekly and were given AIN93G pellets (Research
diet,USA)andwateradlibitumforsixweekstoinduceADR-
inducedproteinuria,which hasbeenwellcharacterized asthe
experimental model for nephrotic syndrome [1].
Afterthesix week ofinduction,ratsreceivedeitheralow-
protein/high-fat diet (7% of calories derived from protein
and 40% from fat) or a high-protein/low-fat diet (30% of
calories from protein and 7% from fat) for the remaining ﬁve
weeks.
2.3. Analysis of Blood Samples. A 12-hour overnight fasting
blood was collected at 0 and ﬁve weeks after feeding experi-
mental diet. Rats were lightly anesthetized with ethyl ether,
and blood samples were taken by heart puncture. Blood
samples were immediately collected in EDTA-containing
tubes and serum-separating tubes (SSTs) to separate the
plasma and serum. Blood was centrifuged at 3,000rpm for
15min at 4◦C, and the top layer (serum) was stored at
−70◦Cuntiluseinassaysforserumlipidproﬁle(TG,T-Chol,
LDL-C, and HDL-C), kidney function (BUN, creatinine;
sCr), and serum albumin level. We used a solid-phase
sandwich enzyme-linked immunosorbent assay (ELISA) to
measure albumin levels. A colored product was produced
by bounding enzyme following the addition of a substrate
solution, and the absorbance was measured at 595nm.
Albumin concentration was calculated relative to a standard
curve. Serum lipid levels were determined using commercial
k i t s( A s a nC oL t d ,S e o u l ,K o r e a ) ,a sw e r es e r u mB U Na n d
creatinine levels (BioAssay System, Hayward, USA).
2.4. Analysis of Urine Samples. For 24-hour urine collection,
animals were housed in metabolic cages. During the urinary
collection period, rats were restricted from food to avoid
contaminating the urine. They were, however, allowed free
access to water. Instruments used to collect urine were
washed with 0.1N HCl to prevent rot. Urine samples were
centrifuged at 2,000rpm for 15min at room temperature,
and the top layer was stored at −70◦Cu n t i lu s e dt o
assay kidney function parameters (proteinuria, UUN, UCr).
Urinary protein was measured using the Bradford method,
which relies on protein binding to Coomassie Blue G-250
(BioRad no. 500-0201) dye. Urinary urea nitrogen (UUN)
and urinary creatinine were determined using commercial
kits (BioAssay System, Hayward, USA).
2.5. Hepatic Lipid Proﬁle. After blood collection, a portion
of the liver was frozen in liquid nitrogen and maintained
at −70◦C until assayed. Total lipid was extracted from liver
using Folch’s method. The extracted samples were dried
under nitrogen gas, resolved in 2-propanol containing 10%
Triton X-100 (wt:wt), and subjected to measurement of
the lipid components. Triglyceride and total cholesterol
concentration were determined using enzyme assay kits
(Asan Pham Co., Seoul, Korea).
2.6. Clinical Parameters. Creatinine clearance (Ccr) was
calculated according to the following formula [18]:
Ccr(mL/min) =
Ucr

mg/day

Scr

mg/mL

× 1,440

min/day
,( 1 )
where Ccr is creatinine clearance, Ucr is urinary creatinine,
Scr is serum creatinine, and 1,440 = 24h ×60 min.Mediators of Inﬂammation 3
Table 1: Body weights, food intakes,FER, and organ weights.
LPHF(1) HPLF(2)
Initial body weight (g) 374.3±11.4 366.4±16.4
Final body weight (g) 415.5±13.0 411.5±12.1
Weight gain (g) 41.2±10.3 40.0±8.5
Calories intake (kcal/day) 58.4±0.5 58.0±0.3
FER(3) 0.4±0.1 0.5±0.1
Liver (g) 12.2±0.6 11.9±1.0
Spleen (g) 0.7±0.1 0.8±0.2
Kidney (g) 2.6±0.1 3.4±0.6∗
Heart (g) 1.2 ±0.1 1.2±0.1
(1)LPHF: weekly intraperitoneal injection of adriamycin (2mg/kgBW) for 6 weeks thereafter a 7% protein and 40% fat diet for 5 weeks.
(2)HPLF: weekly intraperitoneal injection of adriamycin (2mg/kgBW) for 6 weeksthereafter a 30% protein and 7% fat diet for 5 weeks.
(3)FER: food eﬃciency ratio: (weight gain (g))/(food consumed(kcal)/day).
∗Statisticaldiﬀerence between the HPLF and LPHF groups by Student’s t-test at P<. 05.
2.7. Inﬂammatory Cytokine Proﬁle. Proinﬂammatory (IL-
1β,I L - 6 ,a n dT N F - α) and anti-inﬂammatory (IL-4, IL-
10 and IL-13) cytokines were measured in duplicate using
Millipore’s MILLIPLEX rat cytokine panel (Millipore, Bil-
lerica, Mass). Using multiplex technology, all cytokines in
the panel were measured simultaneously. All assays were
conductedaccording to the manufacturer’s instructions. The
plate was run on a Luminex 200 Instrument using Bio-
Plex Manager 4.1 standard software (Bio-Rad Laboratories,
Hercules, Calif). Raw ﬂuorescence data were analyzed by
the software using a ﬁve-parameter logistic method. The
minimum detection concentrations were 1.8, 1.0, 0.4 and
6.3pg/mL for IL-6, TNF-α, IL-4, and IL-13, respectively. The
intra- andinterassayprecisions oftheratcytokinepanelwere
2.16–9.12% and 3.11–5.86%, respectively.
2.8. Primary Spleen Cells Culture. Spleens were isolated, and
single-splenocyte suspensions were prepared and adjusted
to 2×106 cells/mL in RPMI 1640 supplemented with 10%
FBS, 1% 5×10−5 M 2-mercaptoethanol, and 1% antibiotic
antimycotic solution (Sigma). Cell suspensions were plated
in 24-well ﬂat-bottom culture plates at 1mL per well in
t h ep r e s e n c eo fL P S( 5μg/mL) and ConA (5μg/mL). Each
culture was maintained for 24h at 37◦Ca n d5 %h u m i d i t y .
2.9. Statistical Analysis. All measurements were performed
in duplicate, and statistical calculation was performed with
SPSS statistical software for Windows version 13.0. All
data are presented as mean ±SD. Diﬀerences in measured
parameters between the experimental groups were analyzed
using Student’s t-test. The diﬀerences were considered to be
signiﬁcant when the P- v a l u ew a sl e s st h a n. 0 5 .
3.Results
3.1. Body Weight, Calorie Intake, Food Eﬃciency Ratio,
and Organ Weights. The eﬀects of dietary protein and
fat contents on weight, calorie intake, the food eﬃciency
ratio (FER), and organ weights are shown in Table 1.T h e
baseline body weight of LPHF and HPLF diet groups were
374.3±11.4 and 366.4±16.4g, respectively. Five weeks of
feeding the experimental diets did not aﬀect the ﬁnal body
weights (415.5±13.0g and 411.5±12.1g, resp.). Calorie
intake (58.4±0.5 and 58.0±0.3kcal/day, resp.) and FER
(0.4±0.1and 0.5±0.1,resp.)were notsigniﬁcantly diﬀerent
between the groups.
After feeding the experimental diets for ﬁve weeks, the
average weights of liver, spleen, and heart did not diﬀer
between the groups. However average kidney weight of the
HPLF group (3.4±0.6g) was signiﬁcantly higher than that
of the HPLF (2.4±0.1g) group (P<. 05).
3.2. Blood and Hepatic Lipid Levels. The eﬀects of experi-
mental diets on the levels of blood and hepatic lipids are
shown in Figure 1. The serum triglyceride (TG) level in
the LPHFgroup(186.9±5.6mg/dL)wassigniﬁcantlyhigher
than that in the HPLF group (170.9±6.4mg/ dL) (P<. 01);
however, it did not diﬀer from the baseline value (177.9±
5.3mg/dL). The serum T-chol levels were not diﬀerent
between the groups, both of which (186.7±8.8mg/dL,
and 182.0±11.1mg/dL, resp.) were signiﬁcantly higher
than the baseline value (94.1±10.1mg/dL, P<. 001).
The serum level of LDL-chol was signiﬁcantly higher in
the HPLF (15.0±3 . 5 m g / d L )t h a ni nt h eL P H Fg r o u p
(7.5±1.1mg/dL), both of which were signiﬁcantly higher
than the baseline value (5.8±0.5mg/dL, P<. 05). The
serum HDL-chol levels were signiﬁcantly lower in the LPHF
group (32.4±6.0mg/dL) than in the HPLF group (68.1±
11.1mg/dL) (P<. 01), with that of the LPHF group being
signiﬁcantly lower than the baseline value (50.4±4.5mg/dL,
P<. 05).
The hepatic TG contents were signiﬁcantly higher in
the LPHF group (189.1±17.3mg/dL) than those in the
HPLF group (100.5±9.4mg/dL) (P<. 01) both of which
were signiﬁcantly higher and lower than the baseline
value, respectively (P<. 001, P<. 05). The hepatic
contents of T-chol were also signiﬁcantly higher in the
LPHF group (95.8±10.4mg/dL) than in the HPLF group4 Mediators of Inﬂammation
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Figure 1: Serum and hepatic lipids. NS: weekly intraperitoneal injection of adriamycin (2mg/kgBW) for six weeks. LPHF: weekly
intraperitoneal injection of adriamycin (2mg/kgBW) for 6 weeks thereafter a 7% protein and 40% fat diet for 5 weeks. HPLF: weekly
intraperitoneal injection of adriamycin (2mg/kgBW) for 6 weeks thereafter a 30% protein and 7% fat diet for 5 weeks.TG: triglyceride, T-
chol: total-cholesterol, LDL-chol: LDL-cholesterol, HDL-chol: HDL cholesterol. ∗Statisticallydiﬀerent between the LPHF and HPLF groups
by student’s t-test at P<. 05, ∗∗P<. 01, ∗∗∗P<. 001.
(64.4±6.9mg/dL) (P<. 001) both of which were signiﬁ-
cantlyhigher than thebaseline value(40.3±6.2mg/dL)(P<
.05).
3.3. Blood and Urinary Clinical Parameters. The eﬀects of
dietary protein and fat contents on blood and urinary
clinical parameters are shown in Figure 2.T h es e r u ml e v e l
o fa l b u m i ni nt h eL P H Fg r o u p( 3 . 9 ±0.1g/dL) was higher
that of the HPLF group (3.4±0.3g/dL) showing these
values were signiﬁcantly lower than the baseline value
(4.1±0.1g/dL) (P<. 05). The mean levels of BUN in the
LPHF group was 8.3±0.6mg/dL and that of HPLF group
was 16.1±1.2mg/dL, both groups were signiﬁcantly lower
than the baseline value (19.5±0.7mg/dL, P<. 01). The sCr
level in the LPHF group was 0.50±0.05mg/dL and that of
theHPLFgroupwas0.36±0.05mg/dL,those ofbothgroups
were signiﬁcantly higher and lower than the baseline values,
respectively (P<. 01).
Urinary protein excretion in the HPLF group (178.6±
55.9mg/24hmL) was signiﬁcantly higher than that in
the LPHF group (95.7±10.5mg/24hmL), and both
were signiﬁcantly higher than the baseline value (72.8±
9.6mg/24hmL, P<. 0 5 ) .T h el e v e lo fU U Ni nt h e
HPLF group (178.3±24.7mg/dL) was higher than that
of the LPHF group (66.3±11.1mg/dL) and the baseline
value (81.0±13.0mg/dL) (P<. 001). The Ucr level ofMediators of Inﬂammation 5
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Figure 2: Blood and urinary clinical parameters. NS: weekly intraperitoneal injection of adriamycin (2mg/kgBW) for six weeks. LPHF:
weekly intraperitoneal injection of adriamycin (2mg/kgBW) for 6 weeks thereafter a 7% protein and 40% fat diet for ﬁve weeks. HPLF:
weeklyintraperitonealinjection ofadriamycin(2mg/kgBW)for6weeksthereafter a30%protein and7%fatdiet forﬁveweeks. BUN:blood
urea nitrogen, Scr: serum creatinine. UUN: urinary urea nitro g e n ,U c r :u r i n a r yc r e a t i n i n e ,C c r :c r e a t i n i n ec l e a r a n c e .∗Statistical diﬀerence
between groups by Student’s t-test at P<. 05, ∗∗P<. 01, ∗∗∗P<. 001.
the LPHF group was 135.8±18.8mg/dL, and that of
the HPLF group was 71.2±5.1mg/dL (P<. 001), both
values were signiﬁcantly higher than the baseline values
(60.1±6.1mg/dL, P<. 05).
The creatinine clearance (Ccr) of the LPHF group
was 1.4±0.2mL/min and that of the HPLF group was
1.4±0.2mL/min, showing a signiﬁcant diﬀerence (P<
.05). Ccr of both groups were signiﬁcantly lower than the6 Mediators of Inﬂammation
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Figure 3: Inﬂammatory cytokines levels in splenocyte supernatant. LPHF: weekly intraperitoneal injection of adriamycin (2mg/kgBW) for
six weeks thereafter a 7% protein and 40% fat diet for ﬁve weeks. HPLF: weekly intraperitoneal injection of adriamycin (2mg/kgBW) forsix
weeks thereafter a 30% protein and 7% fat diet for ﬁve weeks. ∗Statistical diﬀerence between the LPHF and HPLF groups by Student’s t-test
at P<. 05, ∗∗P<. 01.
baseline values (2.13±0.05min/mL, P<. 05) (data not
shown).
3.4.Serumand SplenocyteSupernatant Levels ofInﬂammatory
Cytokines. The eﬀects of dietary protein and fat on serum
inﬂammatory cytokine levels are shown in Table 2.T h e
serum levels of neither the Proinﬂammatory cytokines (IL-
1β,I L - 6 ,a n dT N F - α) nor the anti-inﬂammatory cytokines
(IL-4, IL-10, and IL-13) in the experimental groups did not
diﬀer signiﬁcantly. Serum levels of IL-1β in LPHF group,
and IL-6, TNF-α and IL-13 levels in HPLF group were
signiﬁcantly lower than each of the baseline values (P<. 05).
The eﬀects of dietary protein and fat composition on
splenocyte supernatant levels of inﬂammatory cytokines are
shown in Figure 3. The splenocyte supernatant levels of
Proinﬂammatory cytokines, IL-6 and TNF-α,i nt h eL P H F
group (374.0±27.0pg/mL and 75.2±17.7pg/mL, resp.)
were signiﬁcantly higher than those of the HPLF group
(245.5±45.5pg/mL, and 44.0±15.2pg/mL, resp.) (P<
.05), whereas IL-1β in the splenocyte supernatant did not
diﬀer between the groups. The splenocyte supernatant level
of theanti-inﬂammatory cytokine,IL-13, in the LPHFgroup
(6.40±0.36pg/mL) was signiﬁcantly higher than that of
HPLF group (5.25±0.43pg/mL) (P<. 05), whereas the IL-4
and IL-10 levels did not diﬀer between the groups.Mediators of Inﬂammation 7
Table 2: Serum levels of inﬂammatory cytokines.
LPHF(1) HPLF(2)
Proinﬂammatory cytokines (pg/mL)
IL-1β 23.5±1.1 29.3±9.0
IL-6 113.4±84.2 95.8±23.5
TNF-α 3.0±0.3 2.8±0.2
Anti-inﬂammatory cytokines (pg/mL)
IL-4 23.8±2.4 25.8±3.6
IL-10 3.1±0.4 3.7±0.9
IL-13 44.7±4.4 52.4±19.6
(1)LPHF: weeklyintraperitoneal injection of adriamycin(2mg/kgBW) for 6
weeks thereafter a 7% protein and 40% fat diet for ﬁve weeks.
(2)HPLF: weeklyintraperitonealinjection of adriamycin(2mg/kgBW)for 6
weeks thereafter a 30% protein and 7% fat diet for ﬁve weeks.
No statistical diﬀerence between the LPHF and HPLF groups by Student’st-
test at P<. 05.
4.Discussion
This study was conducted to investigate the eﬀects of dietary
protein and fat contents on renal function and inﬂamma-
tory cytokine levels in rats with nephrotic syndrome. We
induced nephrotic syndrome to the rats by intraperitoneal
injection of ADR (2mg/kgBW) for six weeks, followed
by a low-protein/high-fat (C:P:F=53:7:40, LPHF) or
a high-protein/low-fat (C:P:F=63:30:7, HPLF) diets to
the rats for ﬁve weeks. The main symptoms of nephrotic
syndrome might be hypoalbuminemia, hyperlipidemia, and
proteinuria [1–3]. First of all, we could observe that serum
albumin levels decreased and serum lipid levels increased,
as well as urinary protein increased. Hence, in accord with
previous ﬁndings, these results ascertained the symptoms
of nephrotic syndromes had been developed before the
treatment of experimental diets.
To prevent the eﬀects of diﬀerent amount of calories
from the experimental diets, we oﬀered isocalorie diets
with diﬀerent protein:fat ratios. Consequently, weight gain,
calorie intake, and FER did not diﬀer signiﬁcantly between
the two diet groups.
In nephrotic syndrome rats, the kidney size might
increase because of the damages from excessive urinary
protein loss and inﬂammation. Previous studies reported
that a high-protein diet caused the kidney damage more
than a low-protein diet did [19, 20]. In our study, the
kidney weights of the high-protein/low-fat diet group were
signiﬁcantly higher than those of low-protein/high-fat diet
group. Renal hypertrophy may be developed by kidney
overload due to the considerable protein in the HPLF diet.
Generally, it is well known that rats with nephrotic
syndrome had signiﬁcantly higher plasma lipid levels caused
by variations of oncotic pressure due to proteinuria,
compared with normal rats [21, 22]. It is also reported
that hyperlipidemia in nephrotic syndrome can be more
aggravated by abnormalities of various lipoproteins [23].
In patients with nephrotic syndrome, liver production and
secretion of cholesterol-rich lipoproteins increased, and
cholesterol removal in blood circulation decreased. It was
proven that the overproduction of lipoproteins results in
their accumulation in the livers of the rats with nephrotic
syndrome [21, 24]. In this study, the serum levels of TG in
the two experimental diet groups were similar to those at
baseline, though the serum TG level of the HPLF group was
signiﬁcantly lower than those of the LPHF group. On the
other hand, T-chol levels of both groups were higher than
the baseline values, though the levels of the HPLF and LPHF
groups were similar to one another.
Additionally, some studies have reported that hyper-
lipidemia is signiﬁcant due to high serum TG and T-chol
levels in high-fat diet [25, 26]. In this study, LDL-chol and
HDL-chol of the LPHF group were higher than those at
baseline. Therefore it is considered that the hyperlipidemia
in LPHF group is signiﬁcant due to the large portion of fat in
diet. However, additional studies are needed to identify the
mechanisms of increased LDL- and HDL-chol levels in high
protein diet.
Generally, it is known that injury to podocyte foot
processes in the kidney causes protein excretion into the
urine [27]. In fact, proteinuria indicates a decline of renal
function [28–30] and it is known that ADR injection causes
proteinuria, as shown previously [2, 3, 29, 30]. In our
study, the experimental diets were provided after inducing
proteinuria by ADR injection. Urinary protein excretions
after dietary treatments were signiﬁcantly diﬀerent and
which werehigher thanthatofbaselinevalue.Itisconsidered
that the increased protein excretion due to high-protein diet
is consistent with previous studies, and consequently the
progress of nephrotic syndrome in HPLF group was more
advanced than that of LPHF group.
Serum albumin, BUN, sCr, UUN, Ucr, and Ccr are
known as indicators about renal dysfunction [31–33]. As
seen above, we could develop the symptoms of nephrotic
syndrome in our animal model. Then, we could explore the
eﬀect of dietary protein and fat contents on renal function.
Each diet advanced the progress of nephrotic syndrome,
as evidenced by serum albumin and urinary protein levels
compared with the values at baseline. It is considered that a
lower serum albumin level in the HPLF group indicates that
nephrotic syndrome progressed further in the HPLF group
than in the LPHF group. After dietary intervention for 5
weeks, the BUN and UUN of both groups were lower than
those at baseline. The BUN and UUN in the HPLF group
were signiﬁcantly higher than those of the LPHF group,
indicating negative inﬂuence of high-protein diet on the
renal function. The sCr and Ucr in the HPLF group were
lower than baseline, and the levels of the LPHF group were
higher thanthoseoftheHPLFgroup.Thus, theexperimental
diets have no inﬂuence on the levels of sCr and Ucr. The Ccr
in theHPLFgroupwas higherthan baseline,while thatofthe
LPHF group was lower than baseline. These results could be
speculated that high protein in the HPLF diet might cause
hyperﬁltration, whereas high fat in the LPHF might cause
hypoﬁltration [31, 32].
Generally, nephrotic syndrome has been known to
be associated with a variety of abnormalities in immune
response. Thus, inﬂammatory cytokines in nephrotic syn-
drome are related to increased ROS production due to8 Mediators of Inﬂammation
proteinuria [34]. In addition, a high-fat diet decreases
immune responses due to lipid peroxidation in kidney [33,
34].
Previous studies have shown that the expressions of
Proinﬂammatory cytokines, IL-6 and TNF-α,b o t hi n c r e a s e
in nephrotic syndrome [34–36]. The ADR injection aﬀects
renal function which is inﬂuenced by the diet, thereby
inﬂuencing the levels of serum Proinﬂammatory cytokines.
In this study, the levels of these cytokines in serum and
in the splenocyte supernatant were measured in diﬀerent
dietary group. After feeding diﬀerent diets, serum levels of
inﬂammatory cytokines did not diﬀer between the dietary
groups. However levels of IL-6 and TNF-α in splenocyte
supernatant were signiﬁcantly lower in the HPLF group than
in the LPHF group.
The level of anti-inﬂammatory cytokine, IL-13 was also
signiﬁcantly lower in the HPLF group than that in the LPHF
group. Carefully it can be said that splenocyte’s function
may be more damaged by a high-protein diet than by a
low-protein diet. However, this result diﬀers from those of
previous studies [37–39]. The reasons of this discrepancy
are not clear at present. Therefore we calculated the ratio
of IL-6 to IL-13 in splenocyte supernatant as the balance
between pro- and anti-inﬂammatory cytokines. The ratio of
IL-6 to IL-13 in the HPLF group was higher than the value
at the baseline, conﬁrming an increase in Proinﬂammatory
cytokines, while the ratio in the LPHF group was lower than
the baseline value, showing a decrease in Proinﬂammatory
cytokines (data are not shown).
This study found that a low-protein/high-fat diet may
improve renal function in nephrotic syndrome as indi-
cated by proteinuria, serum album level, BUN, and UUN.
Furthermore, this diet might improve inﬂammatory state
in nephritic syndrome rats through protecting splenocyte
immune function. Accordingly, varying dietary protein
and fat in nephrotic syndrome inﬂuence renal function
and inﬂammatory state. Furthermore, we need to explore
minutely the eﬀects of various diet compositions on renal
function in nephrotic syndrome animal model.
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